SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-016244
Filing Date
2020-03-04
Accepted
2020-03-04 17:10:05
Documents
1
Period of Report
2020-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3977
  Complete submission text file 0001209191-20-016244.txt   5331
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 20688251